日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Cost-effectiveness of nivolumab compared with surveillance for adjuvant treatment of muscle-invasive urothelial carcinoma at high risk of recurrence in France

在法国，对于复发风险高的肌层浸润性尿路上皮癌患者，使用纳武利尤单抗进行辅助治疗与监测相比的成本效益分析

期刊:World Journal of Urology
影响因子:2.9
doi:10.1007/s00345-025-05589-2
Negrier, Sylvie; Bonastre, Julia; Colrat, Florian; Teitsson, Siguroli; Knight, Christopher; Ni, Lei; Chevalier, Julie; Branchoux, Sébastien; Rouprêt, Morgan
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Characteristics, management and survival outcomes in patients with muscle-invasive bladder cancer at high risk of recurrence in France: a subgroup analysis from the coblance cohort

法国复发高风险肌层浸润性膀胱癌患者的特征、治疗和生存结局：来自 Coblance 队列的亚组分析

期刊:BMC Urology
影响因子:1.9
doi:10.1186/s12894-025-01792-w
Fraslin, Aldéric; Colrat, Florian; Karimi, Maryam; Bonastre, Julia; Groussard, Karine; Teitsson, Siguroli; Prudent, Alexis; Branchoux, Sébastien; Radvanyi, François; Benhamou, Simone; Allory, Yves; Lebret, Thierry
肿瘤
肿瘤免疫
膀胱癌
发表日期：2025
文献求助 收藏

Population characteristics, management, and survival outcomes in muscle-invasive urothelial carcinoma undergoing radical resection: the MINOTAUR study

接受根治性切除术的肌层浸润性尿路上皮癌患者的人口特征、治疗和生存结局：MINOTAUR 研究

期刊:World Journal of Urology
影响因子:2.9
doi:10.1007/s00345-023-04335-w
Roupret, Morgan; Brouquet, Alice; Colrat, Florian; Diez-Andreu, Pauline; Prudent, Alexis; Chartier, Mélanie; Gaudin, Anne-Françoise; Bugnard, Françoise; Chillotti, Louis; Bénard, Stève; Branchoux, Sébastien; Bellera, Carine; Negrier, Sylvie
TAU
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Challenges in conducting fractional polynomial and standard parametric network meta-analyses of immune checkpoint inhibitors for first-line advanced renal cell carcinoma

对一线治疗晚期肾细胞癌的免疫检查点抑制剂进行分数多项式和标准参数网络荟萃分析的挑战

期刊:Journal of Comparative Effectiveness Research
影响因子:2.5
doi:10.57264/cer-2023-0004
Petersohn, Svenja; McGregor, Bradley; Klijn, Sven L; May, Jessica R; Ejzykowicz, Flavia; Kurt, Murat; Dyer, Matthew; Malcolm, Bill; Branchoux, Sébastien; Nickel, Katharina; George, Saby; Kroep, Sonja
肿瘤
肿瘤免疫
肾癌
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏

Time to next treatment or death as a candidate surrogate endpoint for overall survival in advanced melanoma patients treated with immune checkpoint inhibitors: an insight from the phase III CheckMate 067 trial

对于接受免疫检查点抑制剂治疗的晚期黑色素瘤患者，以下次治疗或死亡时间为总生存期的替代终点指标：来自 III 期 CheckMate 067 试验的启示

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2021.100340
Branchoux, S; Sofeu, C L; Gaudin, A-F; Kurt, M; Moshyk, A; Italiano, A; Bellera, C; Rondeau, V
黑色素瘤
免疫/内分泌
发表日期：2022
文献求助 收藏